Privacy Policy

Privacy Policy of EVTM

EVTM operates the Website Name website, which provides the service.

This page is used to inform website visitors regarding our policies with the collection, use, and disclosure of Personal Information if anyone decided to use our Service, the Website www.jevtm.com.

If you choose to use our Service, then you agree to the collection and use of information in relation with this policy. The Personal Information that we collect are used for providing and improving the Service. We will not use or share your information with anyone except as described in this Privacy Policy.

The terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, which is accessible at Website URL, unless otherwise defined in this Privacy Policy.

Information Collection and Use

For a better experience while using our Service, we may require you to provide us with certain personally identifiable information, including but not limited to your name, phone number, and postal address. The information that we collect will be used to contact or identify you.

Log Data

We want to inform you that whenever you visit our Service, we collect information that your browser sends to us that is called Log Data. This Log Data may include information such as your computer’s Internet Protocol (“IP”) address, browser version, pages of our Service that you visit, the time and date of your visit, the time spent on those pages, and other statistics.

Cookies

Cookies are files with small amount of data that is commonly used an anonymous unique identifier. These are sent to your browser from the website that you visit and are stored on your computer’s hard drive.

Our website uses these “cookies” to collection information and to improve our Service. You have the option to either accept or refuse these cookies, and know when a cookie is being sent to your computer. If you choose to refuse our cookies, you may not be able to use some portions of our Service.

Service Providers

We may employ third-party companies and individuals due to the following reasons:

  • To facilitate our Service;
  • To provide the Service on our behalf;
  • To perform Service-related services; or
  • To assist us in analyzing how our Service is used.

We want to inform our Service users that these third parties have access to your Personal Information. The reason is to perform the tasks assigned to them on our behalf. However, they are obligated not to disclose or use the information for any other purpose.

Security

We value your trust in providing us your Personal Information, thus we are striving to use commercially acceptable means of protecting it. But remember that no method of transmission over the internet, or method of electronic storage is 100% secure and reliable, and we cannot guarantee its absolute security.

Links to Other Sites

Our Service may contain links to other sites. If you click on a third-party link, you will be directed to that site. Note that these external sites are not operated by us. Therefore, we strongly advise you to review the Privacy Policy of these websites. We have no control over, and assume no responsibility for the content, privacy policies, or practices of any third-party sites or services.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. Thus, we advise you to review this page periodically for any changes. We will notify you of any changes by posting the new Privacy Policy on this page. These changes are effective immediately, after they are posted on this page.

Contact Us

If you have any questions or suggestions about our Privacy Policy, do not hesitate to contact us.

EVTM 2018 Symposium Documentation | JEVTM

EVTM 2018 Symposium Documentation

Access all sessions from the 2:nd EVTM Symposium 2018.

Opening session EVTM round table 2018:
– Endovascular Resuscitation current update – T. Rasmussen (US)
– When do truncal hemorrhage patients die and what are we going to do about it – L. Moore (US)
– Experience from EVAR in rAAA- adjunct techniques that can be used in bleeding patients- T. Larzon (SE)
– Lessons learned from clinical experience and training perspectives over the last 5 years – M. Brenner (US)
– Updates on open techniques for hemorrhage control – Role of Endo? Future? Changes in DSTC courses? – K. Boffard (ZA)
– Optimizing endovascular resuscitation for trauma management : A senior trauma surgeon’s perspective – EE. Moore (US)
– First successful REBOA in mass casualty event and other experience at Role 2 MTF – V. Reva (RU)
– Introducing a Trauma Hybrid OR to your trauma service – A. Kirkpatrick (CA)
– Round table discussion 1: EVTM; Endovascular resuscitation and REBOA – Where do we stand? Where do we go?

Session 1: EVTM practical issues and multidisciplinary approach
– REBOA in South Africa- update and short term lessons – is it really needed? – F. Plani (ZA)
– IR/endovascular role in bleeding control – How to do? How to think? Examples – M. Delle (SE)
– Multidisciplinary early bleeding control interventions in Japan. Who? How? Updates – J. Matsumoto & Y. Matsamura (JP)
– Using endo (and hybrid) techniques in trauma – Evidence? Guidelines? Trauma surgeon thoughts – L. Handolin (FI)
– Endovascular techniques and imaging in bleeding patients – J. Matsumoto (JP)
– Practical aspects of EVTM implementation at your institution – What ”stuff” do you need? – M. Hoehn (US)
– Effect of EVTM with the Hybrid ER: Innovation in the field of severe trauma – T. Kinoshita (JP)
– Is Multidisciplinary/EVTM concept applicable in the US? Who should do what? – J. Duchesne (US)
– Debate 2.0: EVTM in my hospital – Yes, we do! – B. Kessel & O. Galili (IL)
– Debate 2.0: EVTM in my hospital – Dream on; Impossible! – G. Oosthuizen (ZA)
– Panel and audience discussion

Session 2: Vascular access in resuscitation, bleeding & trauma patients
– When and for whom should we obtain emergent femoral vascular access on arrival? – T. Williams (US)
– Vascular access in austere environment/on site/battlefield. Update/tips/problems – V. Reva (RU)
– How to close a vascular access? Closure devices – What to use, when? – Z. Rancic (CH)
– Vascular access for non-vascular surgeons/non IR; Feasible? How to learn? Tips? – Y. Matsumura (JP)
– What to use for access in the ER/Surgery/IR suite for access? New devices? Complications – D. Eefting (NL)
– PRO- vascular access on arrival/in the field – We should do it in selected cases – V. Reva (RU)
– Debate 2.0: CON-Vascular access on arrival/in the field- Dangerous; Bad idea! – L. Moore (US)
– Panel and audience discussion

01:59:00
Session 3: Updates on REBOA
– Never do REBOA for chest or CNS injuries? True or myth? – T. Williams (US)
– Should I start in Zone 1 first for every REBOA use? What can I use to confirm position now and in the near future? – E. Benjamin (US)
– Never do REBOA – existing data and contra-indications – J. Duchesne (US)
– Practical aspects of REBOA – Who do you need? What kind of team? Imaging? – M. Hoehn (US)
– Why pREBOA and iREBOA? What does the data tell us? – L. Neff (US)
– On the horizon for vascular access and REBOA – T. Rasmussen (US)
– Clinical trials update – The ABOTrauma registry update – D. McGreevy (SE)
– Clinical trials update – The AORTA study (US) – J. DuBose (US)
– Clinical trials update – The DIRECT IABO study (JP) – Y. Matsamura (JP)
– Israeli experience with REBOA. For trauma and non-trauma: two years experience – B. Kessel (IL) & G. Shaked (IL)
– Panel and audience discussion

3:58:45
Session 4: Zone III REBOA embolization and pelvic bleeders
– Walkthrough of the new pelvic fracture guidelines (Packing/embolization/REBOA) – F. Coccolini (IT)
– Transitioning to a practice using zone 3 for REBOA – practical aspects and tips – J. Ibrahim (US)
– Level 2-3 trauma REBOA – can you manipulate the ”golden hour”? – W. Teeter (US)
– What to do when things go wrong and it ́s bleeding? Cases – J. Tisnado (US)
– Liquid embolisation for the pelvic – data and how to do – A M. Lerardi (IT)
– EVTM and REBOA for pediatric patients – A bridge to far? – L. Neff (US)
– Debate 2.0: PRO- REBOA should always be considered for pelvic bleeders – M. Brenner (US)
– Debate 2.0: CON- REBOA only if pre-peritoneal packing fails – S. Cacala & G. Oosthuizen (ZA)
– Panel and audience discussion

Session 5: Training aspects of endo-resuscitation and residents point of view!
7 min talk + 3 min discussion. Chairs: Megan Brenner and Artai Pirouzram

– The way to do it – Vascular surgeon or interventional radiologist – M. Taudorf (DK)
– REBOA by EM physicians: US perspective and challenges – W. Teeter (US)
– Military aspects of EVTM training and what is relevant in my experience. Training my residents? – M. Martin (US)
– EndoVascular Training and group for advanced endo treatment in trauma (Korean first experience) – S. Chang (KR)
– Radial Artery Access for Angioembolization in Trauma and training aspects – J. DuBose (US)
– Training Courses in the USA – What’s on the horizon and what is needed? To who? – M. Brenner (US) & M. Hoehn (US)
– Debate 2.0: We have to do EVTM/REBOA – K. Mani (Vascular) (SE)
– Debate 2.0: No, We should do EVTM/REBOA – J. Galante (Trauma) (US)
– Panel and audience discussion on training aspects for EVTM – Who should do what?

2:01:20
Session 6: Pre-hospital and military REBOA and EVTM techniques
7 min talk + 3 min discussion
Chairs: Joe DuBose and Viktor Reva
– Military EVTM experience. Data! US military update – M. Northern (US)
– En route transfer REBOA on the battlefield – J. Keränen & L. Handolin (FI)
– REBOA vs alternative minimally invasive techniques for massive pelvic hemorrhage on the battlefield – M. Martin (US)
– ”Beating Heart” vs. ”Non-Beating Heart” Traumatic Cardiac Arrest: Implications for Resuscitation – J. Manning (US)
– Civilian pre-hospital REBOA: update current status and where do we go? – S. Sadek (UK)
– Civilan pre-hospital REBOA: update Japan, possibilities and limitations? -Y. Matsamura (JP)
– Implementing the REBOA-protocol for non-vascular trauma surgeons – F. Plani & G. Oosthuizen (ZA)
– Pre-hospital femoral access and REBOA use might become part of standard combat casualty care capability in the near future, realistic? – L. Neff (US)
– REBOA afloat- an adjunct to military maritime damage control resuscitation and surgery – P. Rees (UK)
– Debate 2.0: PRO: Transfer vascular access and REBOA – is there a role for that in EVTM? Advantages and considerations YES – J. Galante (US)
– Debate 2.0: CON: Transfer vascular access and REBOA – is there a role for that in EVTM? Disadvantages and considerations Don’t – L. Moore (US)
11.50 Round tables discussion 2: On pre-hospital and military EVTM/REBOA and EVTM methods in the field – what is possible? Should we push the limits?

– Mentice lunch satellite symposium – LIVE Patient Simulation – REBOA, team, complication and process management – Experienced ideas on how to setup an effective training program. With Megan Brenner & Lars Lönn

Session 7: Endovascular and hybrid techniques for bleeding control. Chairs: Megan Brenner and Thomas Larzon.
– Sizing endografts for younger patients (Thorax, Abdomen, Iliac, Subclavian) – S. Spiliopoulos (GR)
– Onyx and mechanical embolic agents for bleeding control. Any rationale? – A M. Lerardi (IT)
– Animal SAAP models and REBOA data. Where do we go? – J. Ross (US)
– TEVAR in trauma and bleeders – L. Qingsheng (CN)
– Liver bleeding – how to manage; What to use in visceral bleeding? Optimal imaging? Tips – M. Delle (DE)
– Subclavian, axillary and neck vessels – Technical aspects to hemostasis in the EVTM era – J. Duschene (US)
– Debate: You have to have endografts for EVTM! What every major hospital should have on its shelf – K. Mani (SE)
– Debate: Simple C-arm and some simple tools can make a different. What to use and what to have on the shelf (Europe) – A. Priouzram & T. Hörer (SE)
– Live debate ”what to have in my EVTM kit” and how to use it.

Session 8: More on training and who should do EVTM – We want to do that! Chairs: Joe DuBose and George Oosthuizen.
– Training for fast vascular access – How fast, what is safe? What to consider and how to teach? – D. Eefting (NL)
– The great panel debate: Trauma surgeons vs Emergency doctors v.s Vascular surgeons vs Interventional Radiologists.
How should we use EVTM and when? Training.
– Simulation and working with C Arm – What exist and what can be done? – L. Lönn (DK)
– Perfused models – What exist and what can be done? How to get a good model? Limitations? – E. Benjamin (US)
– Training modalities in EVTM. What’s out there. Benefits and limitations – T. Williams (US)
– Resuscitative balloon occlusion of the aorta (REBOA): a population based analysis of potential trauma patients in Germany – K. Elias (DE)
– Debate 2.0: PRO – With proper training, anyone can do REBOA (and other procedures?) – J. Ibrahim (US)
– Debate 2.0: CON – EVTM and REBOA procedures should be done by professionals! – C-M. Wahlgren & C Montan (SE)
– Panel and audience discussion

Session 9: Vascular injuries EVTM treatment – open and endo; visceral bleeding. Chairs: Todd Rasmussen and Carl M Wahlgren.
– Choosing embolization agent – What, when and how? My favorite tools – R. Lopez (CH)
– Vascular injuries in South Africa-data? Place for Endo? – G. Oosthuizen (ZA)
– Vascular injuries in Brazil-data? First Brazilian EVTM workshop rapport – J. Sahagoff, M. Steinman & B. Pereira (BR)
– Isolated Aortic Abdominal Injury in Blunt Trauma: Two Case Reports and Review of the Literature – B. Raguan (IL)
– More on vascular injuries and strategies. How to do, what to consider? – S. Spiliopoulos (GR)
– Vessels endograft repair for trauma beyond the thoracic aorta – current data & results – US data – J. DuBose (US)
– Choosing embolization agent – What, when and how? These are my favorite tools! – M. Delle (SE)
– TEVAR – The solution for Thoracic Aortic Blunt and Penetrating Trauma- Guidelines and Indications – S. Fajer (IL)

Session 10: Endovascular Resuscitation; What do we know? Translational data and research. Chairs: Boris Kessel and Jim Manning.
– REBOA (ABO) might be used for non-trauma cases – The physiology behind it and why it works?! REBOA should be in eCPR! – K. Nilsson (SE)
– Indications for REBOA and embolization in PPH – when/how? – E. Søvik (NO)
– Retrievable Stents as an Alternative to REBOA for Aortic and Caval Hemorrhage – B. Tillman (US)
– How hybrid trauma management might change ”classic surgery”? Role in cancer surgery? – B. Kessel (IL)
– Thoracic injuries and intra-opeartive use of REBOA. Experience from Colombia – Ordoñez (CO)
– Cardiac arrest and REBOA – myth or reality? Bridge to ECMO? – A. Johnson (US)
– Debate 2.0: PRO – REBOA has a role in hemodynamic unstable patients, not only trauma! – F. Plani (ZA)
– Debate 2.0: CON – REBOA is dangerous and has no place in other bleeders! – J. Duchesne (US)

Session 11: Complications, anesthesiological and ICU aspects 1 Chairs: Joe DuBose and Lauri Handolin.
– What complications to expect after endovascular procedure? How to manage it? ICU aspects – P. Skoog (SE)
– What can we learn on the ICU period in REBOA treated patients? Day 2-3-4? – L. Moore (US)
– Endovascular major complications – How to avoid and how to solve. Post-operative considerations – T. Larzon (SE)
– REBOA during CPR – experience/data – Is it effective? Any data? – E. Dogan (SE)
– A new femoral access for REBOA and ECPR by a hybrid technique – L. Lamhaut (FR)
– A place for balloons in the ICU? Endovascular approaches for profound shock states – A. Johnson (US)
– Simulation for aortic occlusion balloon in RAAA – a protocol including all hybrid staff reduces door-to-balloon time – A. Albäck (FI)
– Round tables discussion 3: Where do we stand and how to avoid complications? Optimal ICU care? Role of ICU staff?

Session 12: Complications, anesthisiological and ICU aspects 2; Medical treatment and other adjuncts in bleeding? Chairs: Boris Kessel and Laura Moore.
– Pressure, flow and inflammation: managing the patient undergoing balloon occlusion aorta – S. Kellet (UK)
– Intra-abdominal hypertension and abdominal compartment syndrome in bleeders – Lessons – Z. Rancic (CH)
– ECMO – possible role for Endovascular Resuscitation; When? Who? – M. Larsson (SE)
– ECMO in Endovascular Resuscitation. Data and let’s speculate – L. Lamhaut (FR)
– Antithrombotic treatment in the ICU after EVTM. You have an endograft in. What to do next? Evidence? – P. Skoog (SE)
– Imaging: CT, angio and hybrid suite or semi-hybrid suites – what ́s out there and what’s on the horizon? – M. Taudorf & L. Lönn (DK)
– Debate: Supraceliac hematoma and severe hypotension at trauma laparotomy: left thoracotomy and X-clamp vs. REBOA?
ICU care is way different! – K. Boffard (ZA)
– Debate: Supraceliac hematoma and severe hypotension at trauma laparotomy: left thoracotomy and X-clamp vs. REBOA?
ICU care is quite the same – M. Martin (US)
– Panel and audience discussion
– Update on the JEVTM. Where do we go? – J. DuBose (US)
– EVTM Future aspects, the next EVTM symposium, JEVTM, the EVTM society and closing remarks – T. Hörer (SE)